Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties
作者:John E. Tellew、Marion Lanier、Manisha Moorjani、Emily Lin、Zhiyong Luo、Deborah H. Slee、Xiaohu Zhang、Sam R.J. Hoare、Dimitri E. Grigoriadis、Yves St. Denis、Romano Di Fabio、Enza Di Modugno、John Saunders、John P. Williams
DOI:10.1016/j.bmcl.2010.10.095
日期:2010.12
Antagonists of the corticotropin-releasing factor (CRF) neuropeptide may prove effective in treating stress and anxiety related disorders. In an effort to identify antagonists with improved physico-chemical properties a new series of CRF1 antagonists were designed to substitute the propyl groups at the C7 position of the pyrazolo[1,5-a]pyrimidine core of 1 with heterocycles. Compound (S)-8d was identified as a high affinity ligand with a pK(i) value of 8.2 and a functional CRF1 antagonist with pIC(50) value of 7.0 in the in vitro CRF ACTH production assay. (C) 2010 Elsevier Ltd. All rights reserved.